Health Bulletin 22/ June/ 2024

Published On 2024-06-22 12:05 GMT   |   Update On 2024-06-22 12:05 GMT
Advertisement

Here are the top health news for the day:

 Relief for FMGs: NMC shortens internship period to one year

After announcing its decision to not accept the compensatory certificates obtained by the Foreign Medical Graduates (FMGs), the National Medical Commission (NMC) has now modified its stand on the issue. Issuing a notice on 19.06.2024, the Undergraduate Medical Education Board (UGMEB) of the Commission clarified that all the medical graduates from abroad who have sufficiently compensated classes in physical onsite in lieu of the online classes and who have cleared the equivalent exam to MBBS i.e. the screening test, shall be eligible for one-year mandatory internship.

Advertisement

For more information, click on the link below:

NMC Relief: FMGs Who Have Sufficiently Compensated Classes In Physical Onsite In Lieu Of Online Classes Eligible For One Year Mandatory Internship


Centre notifies anti-paper leak law amid NEET, NET row: Rs 1 crore fine, jail up to 10 years for offenders

Amidst the raging row over alleged irregularities in NEET 2024 this year including paper leak, the Centre has brought a stringent law aiming to curb malpractices and irregularities in competitive examinations. The law entails provisions for a maximum jail term of 10 years and a fine of up to Rs 1 crore for offenders.

Nearly four months after President Dropadi Murmu gave assent to The Public Examinations (Prevention of Unfair Means) Act, 2024, the Personnel Ministry on Friday night issued a notification, saying the provisions of the law will come into force from June 21.

For more information, click on the link below:

Rs 1 Crore Fine, Upto 10 Years Jail For Offenders! Centre Notifies Law To Curb Exam Malpractices Amid NEET Row

Drug Safety Alert: Indian Pharmacopoeia Commission flags ADR linked to Meropenem

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of May, has revealed that the carbapenem antibiotic Meropenem is linked with adverse drug reactions (ADRs) named Acute Generalized Exanthematous Pustulosis (AGEP).
In connection with the above, the Indian Pharmacopoeia Commission (IPC) has cautioned healthcare professionals to diligently monitor the potential occurrence of adverse drug reactions (ADRs) when administering Meropenem.
For more information click on the link below:
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News